A new trading day began on May 23, 2023, with 10x Genomics Inc. (NASDAQ: TXG) stock priced at $55.93, down -6.62% from the previous day of trading. During the day, the shares moved up to $57.10 and dropped to $52.59 before settling in for the closing price of $57.10. TXG’s price has ranged from $23.81 to $58.30 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 48.70% over the past five years. Meanwhile, its annual earnings per share averaged -176.30%. With a float of $90.75 million, this company’s outstanding shares have now reached $115.62 million.
Let’s look at the performance matrix of the company that is accounted for 1243 employees.
10x Genomics Inc. (TXG) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Health Information Services Industry. The insider ownership of 10x Genomics Inc. is 1.50%, while institutional ownership is 90.30%. The most recent insider transaction that took place on May 23, was worth 143,271. In this transaction Chief Executive Officer of this company sold 2,602 shares at a rate of $55.06, taking the stock ownership to the 893,190 shares. Before that another transaction happened on May 15, when Company’s Chief Executive Officer sold 2,000 for $53.35, making the entire transaction worth $106,702. This insider now owns 895,792 shares in total.
10x Genomics Inc. (TXG) Performance Highlights and Predictions
In its latest quarterly report, released on 3/30/2023, the company reported earnings of -$0.44 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -176.30% per share during the next fiscal year.
10x Genomics Inc. (NASDAQ: TXG) Trading Performance Indicators
Here are 10x Genomics Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.52, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -0.83 in one year’s time.
Technical Analysis of 10x Genomics Inc. (TXG)
10x Genomics Inc. (NASDAQ: TXG) saw its 5-day average volume 0.97 million, a negative change from its year-to-date volume of 0.98 million. As of the previous 9 days, the stock’s Stochastic %D was 65.39%. Additionally, its Average True Range was 2.53.
During the past 100 days, 10x Genomics Inc.’s (TXG) raw stochastic average was set at 81.06%, which indicates a significant increase from 29.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.66% in the past 14 days, which was lower than the 56.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $52.41, while its 200-day Moving Average is $41.33. Nevertheless, the first resistance level for the watch stands at $56.08 in the near term. At $58.85, the stock is likely to face the second major resistance level. The third major resistance level sits at $60.59. If the price goes on to break the first support level at $51.57, it is likely to go to the next support level at $49.83. Assuming the price breaks the second support level, the third support level stands at $47.06.
10x Genomics Inc. (NASDAQ: TXG) Key Stats
With a market capitalization of 6.16 billion, the company has a total of 116,192K Shares Outstanding. Currently, annual sales are 516,410 K while annual income is -166,000 K. The company’s previous quarter sales were 134,290 K while its latest quarter income was -50,750 K.
